392 research outputs found

    Patterns, aetiology and risk factors of intimate partner violence-related injuries to head, neck and face in Chinese women

    Get PDF
    published_or_final_versio

    Territory-wide ventriculoperitoneal shunting outcomes from 2009 to 2011: Multicenter Hospital Authority Clinical Audit

    Get PDF
    Free paper 7Meeting Theme: Degenerative Lumbar SpineVentriculoperitoneal (VP) shunting for the management of hydrocephalus is one of the most common procedures performed in daily neurosurgical practice. Although surgical techniques and perioperative management have reduced the incidence of shunt failure, the procedure is still fraught with potential complications. Approaching a third of adult patients (29%) experience shunt failure within the first year and as high as 59% of patients regardless of age require shunt revision during their lifetime1. The aim of this study is to determine the rate of shunt failure in Hong Kong’s public health system and identify its causes as well as risk factors …published_or_final_versio

    Long-term remission of myopic choroidal neovascular membrane after treatment with ranibizumab: a case report

    Get PDF
    <p>Abstract</p> <p>Introduction</p> <p>Myopia has become a big public health problem in certain parts of the world. Sight-threatening complications like choroidal neovascularisation membranes occur in up to 10% of pathological myopia, and natural history studies show a trend towards progressive visual loss. There are long-term financial and quality-of-life implications in this group of patients, and treatment strategies should aim for long-term preservation of vision.</p> <p>Case presentation</p> <p>A 56-year-old Caucasian woman presented with a best-corrected visual acuity of 6/6-1 in her right eye and 6/24 in her left. Fundal examination revealed pathological myopia in both eyes and an elevated lesion associated with pre-retinal haemorrhage in the left macula. Ocular coherence tomography and fundus fluorescein angiogram confirmed a subfoveal classic choroidal neovascularisation membrane. The patient decided to proceed with intravitreal ranibizumab (0.5 mg) therapy. One month after treatment, best-corrected visual acuity improved to 6/12 in her left eye, with complete resolution subretinal fluid on ocular coherence tomography. After three months, best-corrected visual acuity further improved to 6/9, which was maintained up to 16 months post-treatment.</p> <p>Conclusion</p> <p>We suggest intravitreal ranibizumab as an alternative treatment for long-term remission of myopic choroidal neovascular membrane. It also suggests that myopic choroidal neovascularisation membranes may require fewer treatments to achieve sustained remission. Furthermore, this could serve as a feasible long-term management option if used in conjunction with ocular coherence tomography.</p
    corecore